Clinical Trial Update: Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™ [Phase 2]

View source ↗

Summary

Phase 2 dose-selection study evaluating different doses of Grass MATA MLP and Grass MATA using mEECs for efficacy and safety in seasonal allergic rhinitis; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Grass MATA
• Grass MATA MLP (Grass MATA MLP)

Snippet

Sponsor: Allergy Therapeutics | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED